189
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Retrospective Analysis of 10 Cases of Disseminated Nontuberculous Mycobacterial Disease with Osteolytic Lesions

, , , , , & show all
Pages 4667-4679 | Published online: 09 Nov 2021

References

  • Koh WJ. Nontuberculous mycobacteria-overview. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0024-2016
  • Kim CJ, Kim UJ, Kim HB, et al. Vertebral osteomyelitis caused by non-tuberculous mycobacteria: predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature. Infect Dis. 2016;48(7):509–516. doi:10.3109/23744235.2016.1158418
  • Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis. 2017;88(4):308–315. doi:10.1016/j.diagmicrobio.2017.05.01128633901
  • Qiu Y, Zhang J, Li B, Shu H. Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-γ autoantibodies: a case report. Medicine. 2019;98(43):e17609. doi:10.1097/MD.000000000001760931651871
  • Xu X, Lao X, Zhang C, et al. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-γ autoantibody formation. BMC Infect Dis. 2019;19(1):203. doi:10.1186/s12879-019-3771-330819109
  • Leonard MK, Blumberg HM. Musculoskeletal tuberculosis. Microbiol Spectr. 2017;5:2. doi:10.1128/microbiolspec.TNMI7-0046-2017
  • Qiu Y, Zhang J, Liu G, et al. Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions. BMC Infect Dis. 2015;15:47. doi:10.1186/s12879-015-0782-625656710
  • Molter CM, Zuba JR, Papendick R. Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet’s parrot (Psittrichas fulgidus). J Zoo Wildl Med. 2014;45(1):127–133. doi:10.1638/2013-0042R1.124712171
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST17277290
  • Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl2):ii1–ii64.
  • Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535. doi:10.1183/13993003.00535-202032636299
  • Nunes-Costa D, Alarico S, Dalcolmo MP, Correia-Neves M, Empadinhas N. The looming tide of nontuberculous mycobacterial infections in Portugal and Brazil. Tuberculosis. 2016;96:107–119. doi:10.1016/j.tube.2015.09.00626560840
  • Henkle E, Winthrop KL, Le T, Kinh NV, Cuc NTK. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36(1):91–99. doi:10.1016/j.ccm.2014.11.00225676522
  • Browne SK. Anticytokine autoantibody-associated immunodeficiency. Annu Rev Immunol. 2014;32:635–657. doi:10.1146/annurev-immunol-032713-12022224499273
  • Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000;408(6812):600–605. doi:10.1038/3504610211117749
  • Kelchtermans H, Billiau A, Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008;29(10):479–486. doi:10.1016/j.it.2008.07.00218775671
  • Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest. 2007;117(1):122–132. doi:10.1172/JCI3007417173138
  • Krisnawati DI, Liu Y-C, Lee Y-J, et al. Blockade effects of anti-interferon- (IFN-) gamma autoantibodies on IFN-gamma-regulated antimicrobial immunity. J Immunol Res. 2019;2019:1629258. doi:10.1155/2019/162925831275997
  • Hogan JI, Hurtado RM, Nelson SB. Mycobacterial musculoskeletal infections. Infect Dis Clin North Am. 2017;31(2):369–382. doi:10.1016/j.idc.2017.01.00728292541
  • Zhou X, Wu H, Ruan Q, et al. Clinical evaluation of diagnosis efficacy of active mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples. Front Cell Infect Microbiol. 2019;9:351. doi:10.3389/fcimb.2019.0035131681628
  • Huang Z, Zhang C, Fang X, et al. Identification of musculoskeletal infection with non-tuberculous mycobacterium using metagenomic sequencing. J Infect. 2019;78(2):158–169. doi:10.1016/j.jinf.2018.10.002
  • Rahman MM, Rahim MR, Khaled A, Nasir TA, Nasrin F, Hasan MA. Molecular detection and differentiation of mycobacterium tuberculosis complex and non-tuberculous mycobacterium in the clinical specimens by real time PCR. Mymensingh Med J. 2017;26(3):614–620.28919618
  • Bi S, Hu FS, Yu HY, et al. Nontuberculous mycobacterial osteomyelitis. Infect Dis. 2015;47(10):673–685. doi:10.3109/23744235.2015.1040445
  • Kim JH, Jung IY, Song JE, et al. Profiles of extrapulmonary nontuberculous mycobacteria infections and predictors for species: a multicenter retrospective study. Pathogens. 2020;9(11):949. doi:10.3390/pathogens9110949